VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript

Cameron Reynolds: Thank you, everyone. There’s a lot to be taking in at the moment. There’s a tremendous amount going on in the company. And I think as you’ve probably taken from everything we’ve said, we’re tremendously excited with all of the pillars now, which are really coming through. But of course, in this environment, that excitement is tempered with the knowledge that we have to be very careful with our capital, which we have been. We have a lot of sight to a lot of incoming money, which we’ve talked about. We’re also pushing for as many other ways of funding what we do with as well as possible non-dilutively. So we’ll have a lot of information through the rest of the year. So we’re looking forward to hopefully what’s looking to be a strong beta through next year as well as the other exciting breakthroughs that we have.

So thank you very much for your time, and I’m looking forward to speaking to you all soon with updates in all of our pillars. Thanks for your time.

Operator: Thank you. This does conclude today’s teleconference. You may disconnect your lines at this time. Thank you for your participation, and have a great day.